Pentostatin (2′-Deoxycoformycin, dCF) in Patients with Low-Grade (B-T-Cell) and Intermediate- and High-Grade (T-Cell) Malignant Lymphomas: Phase II Study of the EORTC Early Clinical Trials Group (Q60685473)
Jump to navigation
Jump to search
scientific article published on 01 March 1996
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Pentostatin (2′-Deoxycoformycin, dCF) in Patients with Low-Grade (B-T-Cell) and Intermediate- and High-Grade (T-Cell) Malignant Lymphomas: Phase II Study of the EORTC Early Clinical Trials Group |
scientific article published on 01 March 1996 |
Statements
Pentostatin (2'-deoxycoformycin, dCF) in patients with low-grade (B-T-cell) and intermediate- and high-grade (T-cell) malignant lymphomas: phase II study of the EORTC Early Clinical Trials Group (English)
R Sorio
T H Cerny
M Van Glabbeke
S Kaye
1 March 1996